Online inquiry

IVTScrip™ mRNA-Human ANKRD65, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21534MR)

This product GTTS-WK21534MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD65 protein. This product can be used in Ciliated cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001145210.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 441869
UniProt ID E5RJM6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD65, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21534MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK17297MR IVTScrip™ mRNA-Human ANKRD10, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD10
GTTS-WK21564MR IVTScrip™ mRNA-Human ANXA6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANXA6
GTTS-WK12535MR IVTScrip™ mRNA-Human ADGRD2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRD2
GTTS-WK18443MR IVTScrip™ mRNA-Human ALS2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALS2
GTTS-WK21323MR IVTScrip™ mRNA-Human AHNAK2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AHNAK2
GTTS-WK28670MR IVTScrip™ mRNA-Human ARPC4-TTLL3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARPC4-TTLL3
GTTS-WK24302MR IVTScrip™ mRNA-Human APCDD1L, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA APCDD1L
GTTS-WK17924MR IVTScrip™ mRNA-Human ANKRD39, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD39
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW